Get startedLog in
    Picture of Kezar Life Sciences logo

    KZR — Kezar Life Sciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapNeutral
    All News

    Brief: Kezar Life Sciences Announces FDA Has Lifted Partial Clinical Hold On Portola Phase 2A Trial Evaluating Zetomipzomib

    Picture of Kezar Life Sciences logoKezar Life Sciences
    15/07/2025 21:52
    July 15 (Reuters) - Kezar Life Sciences Inc KZR.O:

KEZAR LIFE SCIENCES ANNOUNCES FDA HAS LIFTED PARTIAL CLINICAL HOLD ON PORTOLA PHASE 2A TRIAL EVALUATING ZETOMIPZOMIB FOR THE TREATMENT OF PATIENTS WITH AUTOIMMUNE HEPATITIS

KEZAR LIFE SCIENCES INC - TO REQUEST FDA LIFT HOLD ON ZETOMIPZOMIB IN LN

Source text: ID:nBw30DKgxa

Further company coverage: KZR.O

    Recent news on Kezar Life Sciences

    See all news